Michael Karremann

1.2k total citations
27 papers, 471 citations indexed

About

Michael Karremann is a scholar working on Genetics, Neurology and Molecular Biology. According to data from OpenAlex, Michael Karremann has authored 27 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 8 papers in Neurology and 6 papers in Molecular Biology. Recurrent topics in Michael Karremann's work include Glioma Diagnosis and Treatment (14 papers), Neuroblastoma Research and Treatments (8 papers) and Acute Lymphoblastic Leukemia research (5 papers). Michael Karremann is often cited by papers focused on Glioma Diagnosis and Treatment (14 papers), Neuroblastoma Research and Treatments (8 papers) and Acute Lymphoblastic Leukemia research (5 papers). Michael Karremann collaborates with scholars based in Germany, United States and Netherlands. Michael Karremann's co-authors include Torsten Pietsch, Christof M. Kramm, Johannes Wolff, Gerrit H. Gielen, Monika Warmuth‐Metz, Matthias Dürken, Horst Schroten, Marion Hoffmann, Martin Benesch and Brigitte Bison and has published in prestigious journals such as International Journal of Molecular Sciences, British Journal of Cancer and European Journal of Cancer.

In The Last Decade

Michael Karremann

25 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Karremann Germany 12 279 143 129 120 112 27 471
Saman Shabani United States 14 126 0.5× 132 0.9× 110 0.9× 86 0.7× 48 0.4× 65 573
Sushila Jaiswal India 14 276 1.0× 186 1.3× 55 0.4× 206 1.7× 161 1.4× 72 571
Yoshihiro Tsukamoto Japan 13 284 1.0× 122 0.9× 136 1.1× 48 0.4× 78 0.7× 65 545
George Sfakianos Greece 15 179 0.6× 160 1.1× 117 0.9× 69 0.6× 51 0.5× 51 512
Edward Kachur Canada 12 249 0.9× 145 1.0× 49 0.4× 111 0.9× 108 1.0× 25 624
Daniela Danieli Italy 13 311 1.1× 100 0.7× 134 1.0× 133 1.1× 246 2.2× 29 647
Arvind Rishi United States 12 105 0.4× 80 0.6× 67 0.5× 120 1.0× 76 0.7× 46 456
Kanish Mirchia United States 12 167 0.6× 74 0.5× 120 0.9× 56 0.5× 75 0.7× 46 483
Kevin C. Yao United States 13 105 0.4× 198 1.4× 110 0.9× 218 1.8× 104 0.9× 23 734
Vaishali Suri India 12 125 0.4× 65 0.5× 114 0.9× 88 0.7× 61 0.5× 41 401

Countries citing papers authored by Michael Karremann

Since Specialization
Citations

This map shows the geographic impact of Michael Karremann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Karremann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Karremann more than expected).

Fields of papers citing papers by Michael Karremann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Karremann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Karremann. The network helps show where Michael Karremann may publish in the future.

Co-authorship network of co-authors of Michael Karremann

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Karremann. A scholar is included among the top collaborators of Michael Karremann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Karremann. Michael Karremann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Metselaar, Dennis S., Maria Vinci, Fabio Scirocchi, et al.. (2025). The Complexity of Malignant Glioma Treatment. Cancers. 17(5). 879–879. 5 indexed citations
2.
Sitte, Maren, Ángel M. Carcaboso, Joshua Baugh, et al.. (2023). Boswellic acid formulations are not suitable for treatment of pediatric high-grade glioma due to tumor promoting potential. Journal of Traditional and Complementary Medicine. 14(1). 101–108. 3 indexed citations
3.
Karremann, Michael, Gerrit H. Gielen, Torsten Pietsch, et al.. (2021). Magnetic Resonance Imaging Characteristics of Molecular Subgroups in Pediatric H3 K27M Mutant Diffuse Midline Glioma. Clinical Neuroradiology. 32(1). 249–258. 16 indexed citations
4.
Karremann, Michael, Eva Neumaier‐Probst, Frank C. Schlichtenbrede, et al.. (2020). Revesz syndrome revisited. Orphanet Journal of Rare Diseases. 15(1). 299–299. 16 indexed citations
5.
6.
Crigna, Adriana Torres, Fabia Fricke, Katja Nitschke, et al.. (2020). Inter-Laboratory Comparison of Extracellular Vesicle Isolation Based on Ultracentrifugation. Transfusion Medicine and Hemotherapy. 48(1). 48–59. 40 indexed citations
7.
Papan, Cihan, Michael Karremann, Meike Weis, et al.. (2020). A 28-Day-Old Boy with Multifocal Osteomyelitis Mimicking Non-Accidental Injury. Klinische Pädiatrie. 233(2). 91–93. 4 indexed citations
8.
Erb, Ulrike, Christian Schwerk, Horst Schroten, & Michael Karremann. (2019). Review of functional in vitro models of the blood-cerebrospinal fluid barrier in leukaemia research. Journal of Neuroscience Methods. 329. 108478–108478. 11 indexed citations
9.
März, Martin, Svenja Meyer, Ulrike Erb, et al.. (2018). Pediatric acute lymphoblastic leukemia—Conquering the CNS across the choroid plexus. Leukemia Research. 71. 47–54. 18 indexed citations
10.
Karremann, Michael, Marion Hoffmann, Maria Wiese, et al.. (2017). Haematological malignancies following temozolomide treatment for paediatric high-grade glioma. European Journal of Cancer. 81. 1–8. 4 indexed citations
11.
Karremann, Michael, Gerrit H. Gielen, Marion Hoffmann, et al.. (2017). Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location. Neuro-Oncology. 20(1). 123–131. 170 indexed citations
12.
Vandenhaute, Elodie, Carolin Stump-Guthier, M Losada, et al.. (2015). The choroid plexus may be an underestimated site of tumor invasion to the brain: an in vitro study using neuroblastoma cell lines. Cancer Cell International. 15(1). 102–102. 22 indexed citations
13.
Karremann, Michael, Marion Hoffmann, Martin Benesch, et al.. (2015). Secondary Solid Malignancies After High-Grade Glioma Treatment in Pediatric Patients. Pediatric Hematology and Oncology. 32(7). 467–473. 4 indexed citations
14.
Karremann, Michael, et al.. (2014). The impact of prehydration on the clearance and toxicity of high-dose methotrexate for pediatric patients. Leukemia & lymphoma. 55(12). 2874–2878. 11 indexed citations
15.
Karremann, Michael, Alexander Kühn, Torsten Pietsch, et al.. (2013). Cerebellar location may predict an unfavourable prognosis in paediatric high-grade glioma. British Journal of Cancer. 109(4). 844–851. 22 indexed citations
16.
Karremann, Michael, Katrin Zahn, Eva Neumaier‐Probst, et al.. (2010). From Congenital Dermal Sinus Tract to Extensive Epidural Abscess of the Spine. Klinische Pädiatrie. 222(7). 467–468. 1 indexed citations
17.
Karremann, Michael, Gudrun Fleischhack, Michaela Nathrath, et al.. (2009). Clinical and epidemiological characteristics of pediatric gliosarcomas. Journal of Neuro-Oncology. 97(2). 257–265. 19 indexed citations
18.
Karremann, Michael, Torsten Pietsch, G. Janßen, Christof M. Kramm, & Johannes Wolff. (2008). Anaplastic ganglioglioma in children. Journal of Neuro-Oncology. 92(2). 157–163. 32 indexed citations
19.
Karremann, Michael, et al.. (2008). Koinzidenz von Morbus Basedow und Angelman-Syndrom bei einem 13 Monate alten Jungen. Klinische Pädiatrie. 220(1). 29–31. 1 indexed citations
20.
Karremann, Michael, et al.. (2008). Pediatric giant cell glioblastoma: New insights into a rare tumor entity. Neuro-Oncology. 11(3). 323–329. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saman Shabani Breakdown of academic impact, for papers by Sushila Jaiswal Breakdown of academic impact, for papers by Yoshihiro Tsukamoto Breakdown of academic impact, for papers by George Sfakianos Breakdown of academic impact, for papers by Edward Kachur Breakdown of academic impact, for papers by Daniela Danieli Breakdown of academic impact, for papers by Arvind Rishi Breakdown of academic impact, for papers by Kanish Mirchia Breakdown of academic impact, for papers by Kevin C. Yao Breakdown of academic impact, for papers by Vaishali Suri
Rankless by CCL
2026